CLINICAL RESEARCH
Causal associations of ambient particulate matter 10 and Alzheimer’s disease: result from a two-sample multivariable Mendelian randomization study
More details
Hide details
1
Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China
2
Research Department of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China
3
Hypertension Research laboratory, Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China
These authors had equal contribution to this work
Submission date: 2023-09-29
Final revision date: 2024-01-15
Acceptance date: 2024-02-25
Online publication date: 2024-11-30
Corresponding author
Yuqing Huang
Hypertension Research laboratory, Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Alzheimer’s disease (AD) and ambient particulate matter 10 (PM10) have been associated in epidemiological studies. However, the relationship between PM10 and risk of AD has not been proven to be causal. Thus we used two-sample multivariable Mendelian randomization (MR) to examine this relationship.
Material and methods:
Genome-wide association studies (GWAS) for PM10 from UK Biobank, AD from EBI GWAS and IEU OpenGWAS were used for discovery and replication, respectively. Pooled meta-analysis of the inverse variance weighted (IVW) method was the main method. Sensitivity analyses included MR-Egger regression, weighted median, weighted mode and leave-one-out methods. The multivariable MR model adjusted for education. The MR estimates of causality association were expressed as odds ratios (OR) and corresponding 95% confidence intervals (CI).
Results:
There were in total 17 and 19 genetic variants associated with PM10 in the discovery and replication steps, respectively. In the univariate MR, pooled meta-analysis of genetically predicted PM10 was associated with a 99% increased risk of AD (95% CI: 1.25, 3.15, p = 0.004) per 1 standard deviation (SD) increment of PM10 by IVW, and in the multivariable MR with pooled meta-analysis, we found that each SD increase in PM10 was associated with a 127% increase in the risk of AD (95% CI: 1.33, 3.86, p = 0.002) after accounting for education levels.
Conclusions:
Increased PM10 levels were found to be significantly related to an increased risk of AD. This study provided evidence of genetic prediction of a causal relationship between PM10 and the risk of AD, suggesting that air pollution control may have significant implications for the prevention of AD.
REFERENCES (28)
1.
Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet 2021; 397: 1577-90.
2.
Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers 2021; 7: 33.
3.
Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol 2018; 25: 59-70.
4.
Silva M, Loures C, Alves L, et al. Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci 2019; 26: 33.
5.
Zhang XX, Tian Y, Wang ZT, et al. The epidemiology of Alzheimer’s disease modifiable risk factors and prevention. J Prev Alzheimers Dis 2021; 8: 313-21.
6.
Fu P, Yung K. Air pollution and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 2020; 77: 701-14.
7.
Yuan S, Huang X, Zhang L, et al. Associations of air pollution with all-cause dementia, Alzheimer’s disease, and vascular dementia: a prospective cohort study based on 437,932 participants from the UK biobank. Front Neurosci 2023; 17: 1216686.
8.
Cen J, Jia ZL, Zhu CY, et al. Particulate matter (PM10) induces cardiovascular developmental toxicity in zebrafish embryos and larvae via the ERS, Nrf2 and Wnt pathways. Chemosphere 2020; 250: 126288.
9.
Zhang Y, Jia Z, Rajendran RS, et al. Exposure of particulate matter (PM(10)) induces neurodevelopmental toxicity in zebrafish embryos. Neurotoxicology 2021; 87: 208-18.
10.
de Bont J, Jaganathan S, Dahlquist M, et al. Ambient air pollution and cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses. J Intern Med 2022; 291: 779-800.
11.
Lin FC, Chen CY, Lin CW, et al. Air pollution is associated with cognitive deterioration of Alzheimer’s disease. Gerontology 2022; 68: 53-61.
12.
Norgaard M, Ehrenstein V, Vandenbroucke JP. Confounding in observational studies based on large health care databases: problems and potential solutions – a primer for the clinician. Clin Epidemiol 2017; 9: 185-93.
13.
Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32: 1-22.
14.
Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008; 27: 1133-63.
15.
Tzivian L, Dlugaj M, Winkler A, et al. Long-term air pollution and traffic noise exposures and mild cognitive impairment in older adults: a cross-sectional analysis of the Heinz Nixdorf Recall Study. Environ Health Perspect 2016; 124: 1361-8.
16.
Wu YC, Lin YC, Yu HL, et al. Association between air pollutants and dementia risk in the elderly. Alzheimers Dement (Amst) 2015; 1: 220-8.
17.
Cerza F, Renzi M, Gariazzo C, et al. Long-term exposure to air pollution and hospitalization for dementia in the Rome longitudinal study. Environ Health 2019; 18: 72.
18.
Parra KL, Alexander GE, Raichlen DA, Klimentidis YC, Furlong MA. Exposure to air pollution and risk of incident dementia in the UK Biobank. Environ Res 2022; 209: 112895.
19.
Lee JH, Byun MS, Yi D, et al. Long-term exposure to PM10 and in vivo Alzheimer’s disease pathologies. J Alzheimers Dis 2020; 78: 745-56.
20.
Sevigny J, Chiao P, Bussiere T, et al. The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease. Nature 2016; 537: 50-6.
21.
Moir RD, Lathe R, Tanzi RE. The antimicrobial protection hypothesis of Alzheimer’s disease. Alzheimers Dement 2018; 14: 1602-14.
22.
Woodward NC, Pakbin P, Saffari A, et al. Traffic-related air pollution impact on mouse brain accelerates myelin and neuritic aging changes with specificity for CA1 neurons. Neurobiol Aging 2017;53:48-58.
23.
Heusinkveld HJ, Wahle T, Campbell A, et al. Neurodegenerative and neurological disorders by small inhaled particles. Neurotoxicology 2016; 56: 94-106.
24.
Kritikos M, Gandy SE, Meliker JR, Luft BJ, Clouston S. Acute versus chronic exposures to inhaled particulate matter and neurocognitive dysfunction: pathways to alzheimer’s disease or a related dementia. J Alzheimers Dis 2020; 78: 871-86.
25.
Wu Y, Zhang S, Qian SE, et al. Ambient air pollution associated with incidence and dynamic progression of type 2 diabetes: a trajectory analysis of a population-based cohort. BMC Med 2022; 20: 375.
26.
Liu F, Wang X, Pan M, et al. Exposure to air pollution and prevalence of metabolic syndrome: a nationwide study in China from 2011 to 2015. Sci Total Environ 2023; 855: 158596.
27.
Zhang K, Wang H, He W, et al. The association between ambient air pollution and blood lipids: a longitudinal study in Shijiazhuang, China. Sci Total Environ 2021; 752: 141648.
28.
Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis 2017; 1863: 1037-45.